Pages that link to "Q48878954"

The following pages link to Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression. (Q48878954):

Displaying 25 items.

• Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide (Q28246310) (← links)
• Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis (Q28736049) (← links)
• Antidepressants for old people. GPs should become familiar with one or two antidepressants from each class (Q33797816) (← links)
• Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial (Q34237166) (← links)
• Antidepressant versus placebo for depressed elderly. (Q34281581) (← links)
• How do you define remission? (Q35030854) (← links)
• Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study (Q40316583) (← links)
• Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness (Q40493865) (← links)
• Selective serotonin reuptake inhibitors in older patients. A tolerability perspective (Q41435348) (← links)
• How Safe Are Serotonin Reuptake Inhibitors for Depression in Patients with Coronary Heart Disease? (Q41519173) (← links)
• Neuropsychiatric Aspects of Failure to Thrive in Late Life (Q41630693) (← links)
• Fluoxetine tenth anniversary update: the progress continues (Q41653513) (← links)
• Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study. (Q42681730) (← links)
• Brain metabolic changes associated with symptom factor improvement in major depressive disorder (Q43713436) (← links)
• Fluoxetine: an update of its use in major depressive disorder in adults (Q45186265) (← links)
• Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients (Q48296773) (← links)
• The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome (Q48708771) (← links)
• Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression (Q51080364) (← links)
• Antidepressant Use in the Elderly (Q57382343) (← links)
• Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging (Q73196400) (← links)
• A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression (Q73508039) (← links)
• A Clinical Practice Guideline approach to treating depression in long-term care (Q73528005) (← links)
• The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis (Q74453942) (← links)
• [Treatment of major depressive disorder. Criteria for considering the patient cured after an episode of major depression] (Q82487755) (← links)
• Do SSRIs differ in their antidepressant efficacy (Q88143117) (← links)